Connect with us

World

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

Published

on

White House says deals struck to cut prices of popular Medicare drugs that cost  billion yearly

WASHINGTON (AP) — The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of Medicare’s most popular and costliest drugs, but shared few immediate details about the new price older Americans will pay when they fill those prescriptions.

White House officials said Wednesday night they expect U.S. taxpayers to save $6 billion on the new prices, while older Americans could save roughly $1.5 billion on their medications. Those projections, however, were based on dated estimates and the administration shared no details as to how they arrived at the figures.

Nonetheless, the newly negotiated prices — still elusive to the public as of early Thursday morning — will impact the price of drugs used by millions of older Americans to help manage diabetes, blood cancers and prevent heart failure or blood clots.

The drugs include the blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia. Medicare spent $50 billion covering the drugs last year.

It’s a landmark deal for the Medicare program, which provides health care coverage for more than 67 million older and disabled Americans. For decades, the federal government had been barred from bartering with pharmaceutical companies over the price of their drugs, even though it’s a routine process for private insurers.

Advertisement

“This meant that drug companies could basically charge whatever they want for life-saving treatments people rely on, and all Americans paid the price,” White House adviser Neera Tanden told reporters in a Wednesday night call.

The drug deals will become a focal point for Vice President Kamala Harris’ presidential campaign, especially since she cast the tie-breaking vote to pass the law. She will join President Joe Biden Thursday to announce the drug prices, their first joint speaking appearance since she replaced him at the top of the Democratic ticket, as they both struggle to convince voters that costs will trend down after years of above-normal inflation.

The pair last appeared publicly together to welcome back to the U.S. Americans detained in Russia who were freed as part of a massive prisoner swap earlier this month.

Powerful pharmaceutical companies unsuccessfully tried to file lawsuits to stop the negotiations, which became law in 2022, when a Democratic-controlled Congress passed the Inflation Reduction Act, overhauling several Medicare prescription drug regulations. But executives of those companies have also hinted in recent weeks during earnings calls that they don’t expect the negotiations to impact their bottom line.

The Centers for Medicare and Medicaid Services, which oversaw the dealmaking, is expected to release the final drug prices later Thursday. The new prices won’t go into effect until 2026. Next year, the Department of Health and Human Services can select another 15 drugs for price negotiations.

Advertisement

Before the drug prices were finalized, the Congressional Budget Office estimated the negotiations could save the federal government $25 billion in 2031.

The official event comes a day before Harris is set to unveil part of her economic agenda on Friday in North Carolina, where she was aiming to roll out other ways she plans to help cut costs and boost incomes for the middle class.

Advertisement

World

Tourist dies at luxury resort after cobra from snake show climbs up pants, bites him: police

Published

on

Tourist dies at luxury resort after cobra from snake show climbs up pants, bites him: police

NEWYou can now listen to Fox News articles!

A German tourist has died after a venomous cobra featured in a snake show reportedly slithered up his pants and bit him on the leg, authorities said.

The freak accident occurred early April at a luxury resort destination in Egypt, according to the Bavarian State Police in Germany, which released details Monday.

“During the snake charmer’s performance, one of the snakes crawled into the trousers of a 57-year-old man, resulting in a bite to the German tourist’s leg,” officials said. 

Police said the victim, whose identity was not released, was on vacation with two family members from the Unterallgäu region of Germany.

Advertisement

BILLIONAIRE’S DEATH AFTER SWALLOWING BEE RAISES QUESTIONS ABOUT RARE CARDIAC REACTION

A King Cobra stis up freely while inside a building in April 2010.  (Patrick Aventurier)

Authorities said the snake charmer event was part of a hotel entertainment program in the resort city of Hurghada, a popular Red Sea destination known for its upscale all-inclusive packages, as well as nearby desert and water excursions.

Two snakes, believed to be cobras, were used in the show, officials said. 

Investigators indicated that it is not uncommon for performers to allow snakes to interact closely with audience members, as some of the snakes were reportedly placed around guests’ necks during the act.

Advertisement

However, during one segment of the performance, a snake reportedly bit the German tourist after crawling into his clothing.

“He subsequently exhibited clear symptoms of poisoning and required resuscitation,” officials said. 

He reportedly died shortly after arriving at a local hospital.

LAW STUDENT KILLED BY ELEPHANT DURING VACATION TO THAILAND: OFFICIALS

Tourists swim in the Sunny Days Elpalacio beach in the Egyptian Red Sea resort city of Hurghada. (MOHAMED EL-SHAHED / AFP)

Advertisement

The results of a toxicological examination are still pending, Bavarian police said.

The investigation is being handled by Germany’s Memmingen Criminal Police Inspectorate under the direction of the Memmingen Public Prosecutor’s Office (MPPO).

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Tourists swimming at the Red Sea Egyptian resort of Hurghada on June 18, 2020 (KHALED DESOUKI/AFP)

Cobras are known for being highly venomous snakes. Their bite can lead to rapid respiratory failure and paralysis without prompt medical treatment.

Advertisement

Fox News Digital has reached out to MPPO for more information.   

Continue Reading

World

US appeals court rejects Trump’s immigration detention policy

Published

on

US appeals court rejects Trump’s immigration detention policy

In a 3-0 ruling, court says Trump administration misread a decades-old immigration law to justify mandatory detention.

A United States federal appeals court has rejected the Trump administration’s practice of subjecting most people arrested in its immigration crackdown to mandatory detention without the opportunity to seek release on bond.

In a 3-0 ruling on Tuesday, a panel of the New York-based US Court of Appeals for the Second Circuit said the administration relied on a novel but incorrect interpretation of a decades-old immigration law to justify the policy.

Recommended Stories

list of 4 itemsend of list

Writing for the panel, US Circuit Judge Joseph F Bianco, a Trump appointee, warned that the government’s reading “would send a seismic shock through our immigration detention system and society”, straining already overcrowded facilities, separating families and disrupting communities.

Lawyers for the Trump administration say the mandatory detention policy is legal under the Illegal Immigration Reform and Immigrant Responsibility Act, passed in 1996.

Advertisement

But Bianco said the government had made “an attempt to muddy” the law’s “textually clear waters”, arguing that the administration’s interpretation “defies the statute’s context, structure, history, and purpose” and contradicts “longstanding executive branch practice”.

Under the Trump administration policy, the Department of Homeland Security last year took the position that non-citizens already living in the US, not just those arriving at the border, qualify as “applicants for admission” and are subject to mandatory detention.

Under federal immigration law, “applicants for admission” to the US are detained while their cases proceed in immigration courts and are ineligible for bond hearings.

The Department of Homeland Security has been denying bond hearings to immigrants arrested across the country, including those who have been living in the US for years without any criminal history, the Associated Press (AP) news agency reports.

That is a departure from the practice under previous US administrations, when most non-citizens with no criminal record who were arrested away from the border were given the opportunity to request a bond while their cases moved through immigration court, according to AP.

Advertisement

In such cases, bonds were often granted to people who were deemed not to be flight risks, and mandatory detention was limited to those who had just entered the country.

Amy Belsher, director of immigrants rights’ litigation at the New York Civil Liberties Union, said the appeals court ruling affirmed “that the Trump administration’s policy of detaining immigrants without any process is unlawful and cannot stand”.

“The government cannot mandatorily detain millions of noncitizens, many of whom have lived here for decades, without an opportunity to seek release. It defies the Constitution, the Immigration and Nationality Act, and basic human decency,” Belsher said in a statement.

Conflicting rulings set stage for Supreme Court review

The New York court’s decision comes after two other appeals courts ruled in favour of the Trump administration’s policy.

Acknowledging the opposing rulings, Judge Bianco said the panel was parting ways with them and instead aligning with more than 370 lower-court judges nationwide who have rejected the administration’s position as a misreading of the law.

Advertisement

The split among the courts increases the likelihood that the US Supreme Court will weigh in.

The latest ruling also upheld an order by a New York judge that led to the release of Brazilian national Ricardo Aparecido Barbosa da Cunha, who was arrested by immigration officials last year while driving to work after living in the US for more than 20 years.

“The court was right to conclude the Trump administration can’t just ⁠reinterpret the law at its own whim,” Michael Tan, a lawyer for Barbosa at the American Civil Liberties Union, said in a statement.

The Department of Justice, which is defending the mandatory detention policy in court, did not respond to a request for comment.

Advertisement
Continue Reading

World

‘The Devil Wears Prada 2’ First Reactions Say the Sequel Is ‘Charming,’ ‘Genuinely Heartwarming’ and Destined to ‘Be a Massive Hit’

Published

on

‘The Devil Wears Prada 2’ First Reactions Say the Sequel Is ‘Charming,’ ‘Genuinely Heartwarming’ and Destined to ‘Be a Massive Hit’

Gird your loins, because “The Devil Wears Prada 2” has finally been unveiled to members of the film press and first reactions are trickling in for highly-anticipated sequel. The movie, which marks the return of Meryl Streep to her Oscar-nominated role of fashion magazine powerhouse Miranda Priestly, is being called “charming and fun” and destined to be a “massive hit.”

Entertainment journalist Daniel Baptista wrote on X that “The Devil Wears Prada 2” is a “fun and fierce sequel” that ushers a natural return for stars Streep and Anne Hathaway, adding: “It feels familiar in the best way, timely in the right ways, and is well worth the wait.”

Variety‘s senior artisans editor Jazz Tangcay echoed the praise, writing on X that “‘The Devil Wears Prada 2’ is “phenomenal” and “the perfect sequel that exceeded all expectations. Aline Brosh McKenna’s script is sharp and witty. We’ll be quoting this for years to come. Meryl Streep, Anne Hathaway and Emily Blunt are still great. Stunning costumes, and that soundtrack slaps hard.”

THR senior editor Alex Werpin called the sequel a “biting media parody wrapped up in high fashion,” adding: “Every journalist who sees it will cringe from recognition.”

“‘The Devil Wears Prada 2’ has no right to be as good as it is,” adds Awards Watch’s Erik Anderson. “Just the right kind and number of callbacks and earned nostalgia, Anne Hathaway continues to be our most vibrant star. It’s funny and deeper, and we get the return of ‘Vogue.’”

Advertisement

Meryl Streep returns for “The Devil Wears Prada 2” alongside original cast members Anne Hathaway, Emily Blunt and Stanley Tucci, plus director David Frankel and screenwriter Aline Brosh McKenna. New cast members include Kenneth Branagh, who is set to play Miranda Priestly’s husband, as well as Simone Ashley, Lucy Liu, Justin Theroux, B.J. Novak and more.

While plot details for the sequel have remained under wraps, trailers for “The Devil Wears Prada 2” have revealed that Hathaway’s Andy Sachs returns to Runway to be the magazine’s features editor. In the original, which opened in 2006 and grossed $326 million worldwide, Hathaway’s Andy is an aspiring journalist who becomes the personal assistant to Streep’s Miranda.

The film’s popularity has only skyrocketed in the 20 years since its release, so much so that filming “The Devil Wears Prada 2” on the streets of New York City proved difficult for the cast and crew as fans and paparazzi stormed the shot to follow their every move. Streep told Harper’s Bazaar that she “unnerved” while the filming because of what a sensation it caused.

“Even though we were aware of the impact of the first film two decades ago, I think none of us were prepared for the ambush of both goodwill and avid attention that engulfed us,” Streep said. “We needed police barriers and crowd control. Buses of fans turned up, and paparazzi swarmed and in one case kept jumping in front of the camera and the shot and got in a kerfuffle with crew. Annie kept her cool, but I was unnerved.”

“The Devil Wears Prada 2” kicks off this year’s summer movie season when it opens in theaters May 1 from 20th Century Studios and Disney.

Advertisement

Advertisement
Continue Reading
Advertisement

Trending